Squarepoint Ops LLC Chembio Diagnostics, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $42,082 - $98,450	-38,608 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $55,416 - $143,651	-26,901 Reduced 41.06%	38,608 $97,000
Q2 2021 Aug 16, 2021	BUY	$2.88 - $5.64 $188,665 - $369,470	65,509 New	65,509 $195,000
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $363,412 - $851,881	-106,886 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.11 - $7.51 $439,301 - $802,713	106,886 New	106,886 $508,000
Q4 2019 Feb 14, 2020	SELL	$3.94 - $5.76 $45,018 - $65,813	-11,426 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.84 - $7.25 $35,240 - $52,787	-7,281 Reduced 38.92%	11,426 $70,000
Q2 2019 Aug 14, 2019	BUY	$5.56 - $7.85 $104,010 - $146,849	18,707 New	18,707 $114,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.